Feb 23, 2024 Assignment: Off-Label Drug Use in Pediatrics
Assignment: Off-Label Drug Use in Pediatrics
A Sample Answer For the Assignment: Assignment: Off-Label Drug Use in Pediatrics
The circumstances for prescribing drugs for off-label use by children
Off-Label Use of drugs occurs when patients are given drugs by doctors without the approval of the Food and Drugs Administration (FDA). A patient is sometimes given drugs that were approved to treat another condition that is different from theirs. According to research, three-fourths of prescribed drugs do not have pediatric use information (Frattarelli et al., 2014).In most cases, children are the main victims of off-label drugs prescription due to unavoidable reasons. One of the reasons is that doctors tend to think that a specific drug is effective to a child even if it is not yet approved by the FDA.
This mainly happens because information on drug use in children is rarely found, and therefore this gives health workers a hard time. Off-label drugs are useful in saving children’s lives (Jain et al., 2017). Some diseases like Asthma and Allergies do not have a specific medication for curing the patient but, doctors have prescribed some children to off-label use of drugs in such cases, and the patients tend to show much improvement. For example, there was evidence that showed that aspirin could prevent a second heart attack, and doctors prescribed it as off-label. It was effective, but it took a long time before it was approved.
Strategies for making off-label drugs safer for Children
Off-label drugs are commonly used by many pediatrics in the world, and so there is a need to make them safer for use. There are various strategies that can be used to make off-label drugs safer. One of the strategies is by controlling and managing the promotion of drugs such as prazosin. When it is controlled, the drugs will be used in a minimal number. Another way of making the off-label drugs safer is by creating awareness about the drugs, telling people the advantages and the disadvantages of using the drugs (Pandolfini & Bonati 2016).
Another strategy is by reducing the promotion of off-label drugs at the manufacturer level; this is effective because if they are not manufactured, they will not be available in the market for consumption. The restriction is always another way of dealing with off-label drugs such as clomiphene; for example, if strict safety measures are used, people will not use the drugs (W’t Jong et al., 2015). The government also can help in this by banning the use of off-label memantine drugs and enacting laws that can help to address this issue; nothing tends to be more effective than law.
Struggling to Meet Your Deadline?
Get your assignment on Assignment: Off-Label Drug Use in Pediatrics done on time by medical experts. Don’t wait – ORDER NOW!
Meet my deadline
References
Frattarelli, D. A., Galinkin, J. L., Green, T. P., Johnson, T. D., Neville, K. A., Paul, I. M., & Van,
D. A. (2014). Off-label use of drugs in children. Pediatrics, 133(3), 563-567.
Jain, S. S., Bavdekar, S. B., Gogtay, N. J., & Sadawarte, P. A. (2017). Off-label drug use in
children. The Indian Journal of Pediatrics, 75(11), 1133.
Pandolfini, C., & Bonati, M. (2016). A literature review on off-label drug use in
children. European journal of pediatrics, 164(9), 552-558.
W’t Jong, G., Vulto, A. G., de Hoog, M., Schimmel, K. J., Tibboel, D., & van den Anker, J. N.
(2015). A survey of the use of off-label and unlicensed drugs in a Dutch children’s hospital. Pediatrics, 108(5), 1089-1093.
Click here to ORDER an A++ paper from our Verified MASTERS and DOCTORATE WRITERS Assignment: Off-Label Drug Use in Pediatrics:
Off-label drug use among children is when prescription medications are used to treat conditions not approved for use by the Food and Drug Administration; this practice is widespread; nearly half of the drugs prescribed to kids are used off-label (Meng et al., 2022; Allen et al., 2018). However, its safety and effectiveness remain highly controversial.This paper addresses specific instances when children should receive off-label use drugs as well as strategies that make this practice safer for infants to adolescents.
Circumstances for Prescribe Drugs for Off-Label Use in Children
Children may sometimes require off-label drugs to treat certain conditions effectively. A good example of this is the use of Fluoxetine for OCD, even though the FDA has not approved them for treatment of this disorder (Shuib et al., 2021). Antipsychotic medication could also prove helpful against severe behavioral problems associated with Autism or ADHD, even though only intended for adult treatment.
Off-label drugs may also be prescribed when there are no approved treatments available to pediatric patients; such as when cancer drugs approved by adult medicine have not been studied on children who also suffer from that form of cancer; healthcare providers must carefully weigh potential risks against benefits to ensure that any medication prescribed meets all standards in terms of patient safety and satisfaction.
Strategies for Safer Off-Label Use in Children
Various approaches should be employed when prescribing off-label drugs to children to ensure their safety and efficacy. One strategy involves closely tracking a patient’s medication response and making appropriate dosage changes (Meng, Zhou, et al., 2022). Another strategy might involve pairing the drug with additional therapies like behavioral or psychotherapy sessions for optimal effectiveness and reducing the prescribed dose. Finally, healthcare providers must factor in age, weight and overall health status when prescribing an individualized dosage schedule for every child they treat.
Healthcare providers must exercise extreme care when prescribing off-label drugs to pediatric patients. Opioids like codeine and tramadol that could potentially cause respiratory depression in young children must only be prescribed with consultation from healthcare professionals beforehand, while antibiotics such as tetracyclines have the potential of discoloring tooth enamel; all must be considered carefully to ensure safe and effective off-label drug usage among pediatric patients (Meng, Zhou, et al., 2022). By considering such factors, healthcare providers can ensure the safe and effective usage of off-label medicines among pediatric patients.
Conclusion
Off-label drug usage by children remains a controversial subject. They may be necessary in certain instances; however, when making this decision it should be approached carefully. While limited research exists regarding their safety and efficacy in kids, this might be their only treatment option in certain instances. Healthcare providers must carefully weigh the potential risks and benefits of off-label drug usage among children before prescribing. When administering off-label medicines to kids, various strategies can be employed to safeguard safety and efficacy. One strategy involves closely tracking how well patients react to the medication and making any necessary dosage adjustments accordingly.
Another tactic involves using medication alongside behavioral or psychotherapeutic therapies as complementary measures. When determining an ideal dosage regimen, healthcare providers should also factor in the child’s age, weight, and health status. Being essential in expanding the evidence base and safety when prescribing off-label medicines to children. As research progresses, it is paramount that healthcare practitioners remain diligent in assuring the safe and effective use of off-label medications within pediatric populations.
References
Allen, H. C., Garbe, M. C., Lees, J., Aziz, N., Chaaban, H., Miller, J. L., Johnson, P., & DeLeon, S. (2018). Off-label medication use in children, more common than we think: A systematic review of the literature. The Journal of the Oklahoma State Medical Association, 111(8), 776–783.
Meng, M., Lv, M., Wang, L., Yang, B., Jiao, P., Lei, W., Lan, H., Shen, Q., Luo, X., Zhou, Q., Yu, X., Xun, Y., Lei, R., Hou, T., Chen, Y., & Li, Q. (2022). Off-label use of drugs in pediatrics: a scoping review. European Journal of Pediatrics, 181(9), 3259–3269. https://doi.org/10.1007/s00431-022-04515-7
Meng, M., Zhou, Q., Lei, W., Tian, M., Wang, P., Liu, Y., Sun, Y., Chen, Y., & Li, Q. (2022). Recommendations on off-label drug use in pediatric guidelines. Frontiers in Pharmacology, 13, 892574. https://doi.org/10.3389/fphar.2022.892574
Shuib, W., Wu, X.-Y., & Xiao, F. (2021). Extent, reasons and consequences of off-labeled and unlicensed drug prescription in hospitalized children: a narrative review. World Journal of Pediatrics: WJP, 17(4), 341–354. https://doi.org/10.1007/s12519-021-00430-3
Children, like adults, deal with variety of health issues, but they also have issues that are more prevalent within their population. One issue that significantly impacts children is the prescription of drugs for off-label use. As an advanced practice nurse, how do you determine the appropriate use of off-label drugs in pediatrics? Are there certain drugs that should be avoided with pediatric patients?
ORDER NOW FOR AN ORIGINAL PAPER ASSIGNMENT: Assignment: Off-Label Drug Use in Pediatrics
This week, you examine the practice of prescribing off-label drugs to children. You also explore strategies for making off-label drug use safer for children from infancy to adolescence, as it is essential that you are prepared to make drug-related decisions for pediatric patients in clinical settings.
Learning Objectives
Students will:
Evaluate the practice of prescribing off-label drugs to children
Analyze strategies to make the off-label use of drugs safer for children
Identify key terms, concepts, and principles related to prescribing drugs to treat patient disorders
Learning Resources
Required Readings (click to expand/reduce)
Rosenthal, L. D., & Burchum, J. R. (2018). Lehne’s pharmacotherapeutics for advanced practice providers. St. Louis, MO: Elsevier.
Chapter 8, “Drug Therapy in Pediatric Patients” (pp. 65—67)
Corny, J., Lebel, D., Bailey, B., & Bussieres, J. (2015). Unlicensed and off-label drug use in children before and after pediatric governmental initiatives. The Journal of Pediatric Pharmacology and Therapeutics, 20(4), 316–328. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557722/This article highlights pediatric governmental initiatives to prevent unlicensed and off-label drug use in children. Review these initiatives and guidelines and how they might impact your practice as an advanced practice nurse.
Panther, S. G., Knotts, A. M., Odom-Maryon, T., Daratha, K., Woo, T., & Klein, T. A. (2017). Off-label prescribing trends for ADHD medications in very young children. The Journal of Pediatric Pharmacology and Therapeutics, 22(6), 423–429. doi:10.5863/1551-6776-22.6.423
This study examines the frequency of off-label prescribing to children and explores factors that impact off-label prescribing. This study also examines off-label prescribing to children with ADHD.
Document: Final Exam Study Guide (PDF)
Required Media (click to expand/reduce)
Laureate Education (Producer). (2019i). Therapy for pediatric clients with mood disorders [Interactive media file]. Baltimore, MD: Author.
Assignment: Off-Label Drug Use in Pediatrics
The unapproved use of approved drugs, also called off-label use, with children is quite common. This is because pediatric dosage guidelines are typically unavailable, since very few drugs have been specifically researched and tested with children.
When treating children, prescribers often adjust dosages approved for adults to accommodate a child’s weight. However, children are not just “smaller” adults. Adults and children process and respond to drugs differently in their absorption, distribution, metabolism, and excretion.
Photo Credit: Getty Images
Children even respond differently during stages from infancy to adolescence. This poses potential safety concerns when prescribing drugs to pediatric patients. As an advanced practice nurse, you have to be aware of safety implications of the off-label use of drugs with this patient group.
To Prepare
Review the interactive media piece in this week’s Resources and reflect on the types of drugs used to treat pediatric patients with mood disorders.
Reflect on situations in which children should be prescribed drugs for off-label use.
Think about strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Consider specific off-label drugs that you think require extra care and attention when used in pediatrics.
Assignment: Off-Label Drug Use in Pediatrics
By Day 5 of Week 11
Write a 1-page narrative in APA format that addresses the following:
Explain the circumstances under which children should be prescribed drugs for off-label use. Be specific and provide examples.
Describe strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence. Include descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.
Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http://writingcenter.waldenu.edu/57.htm). All papers submitted must use this formatting.
Submission and Grading Information
To submit your completed Assignment for review and grading, do the following:
Please save your Assignment using the naming convention “WK11Assgn+last name+first initial.(extension)” as the name.
Click the Week 11 Assignment Rubric to review the Grading Criteria for the Assignment.
Click the Week 11 Assignment link. You will also be able to “View Rubric” for grading criteria from this area.
Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK11Assgn+last name+first initial.(extension)” and click Open.
If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.
Click on the Submit button to complete your submission.
Grading Criteria
To access your rubric:Week 11 Assignment Rubric
Check Your Assignment Draft for Authenticity
To check your Assignment draft for authenticity:Submit your Week 11 Assignment draft and review the originality report.
Submit Your Assignment by Day 7 of Week 11
To participate in this Assignment:Week 11 Assignment
Final Exam
This Exam covers the content you have explored throughout this course.
This exam is a test of your knowledge in preparation for your certification exam. No outside resources—including books, notes, websites, or any other type of resource—are to be used to complete this exam. You are not allowed to take screenshots or record the exam questions in any other format while taking the exam. You are expected to comply with Walden University’s Code of Conduct.
Photo Credit: Getty Images
By Day 7 of Week 11
Complete the Final Exam. You have 120 minutes to complete the exam. You may only attempt this exam once.
Submission and Grading Information
Complete the Exam by Day 7 of Week 11
To Complete this Exam:Week 11 Exam
Module in Review
In this module, you evaluated the practice and circumstances of prescribing off-label drugs to children and analyzed the strategies used to make their use and dosage safer for children. After you have completed the Discussion and the Final Exam for this week, you have finished the course. Congratulations! Please complete the Course Evaluation form and submit by Day 7.
Congratulations! After you have finished all of the assignments for this week, you have completed the course. Please submit your Course Evaluation by Day 7.
Assignment: Off-Label Drug Use in Pediatrics
Casey ElBayly WK 9 Discussion
COLLAPSE
In the provided scenario, a 68-year-old male has been hospitalized with community-acquired pneumonia (CAP) for the last three days. He is receiving empiric antibiotics, including ceftriaxone 1 g IV daily and azithromycin 500 mg IV daily. His medical history includes COPD. HTN. hyperlipidemia, and diabetes. He is respiratory status is responding well to treatment, however, he is experiencing nausea, vomiting, and a poor appetite. Current guidelines for the treatment of CAP include treatment with a beta-lactam antibiotic and a macrolide antibiotic (Metlay et al., 2019) He is already receiving ceftriaxone (beta-lactam) and azithromycin (macrolide). These two antibiotics should provide the appropriate coverage for his CAP. Nausea and vomiting are common side effects of antibiotic treatment (Michigan Medicine, n.d.). Using antibiotics changes the bacterial gut flora which can lead to an imbalance, causing nausea and vomiting (Michigan Medicine, n.d.). These symptoms tend to improve over time. This patient should be provided a probiotic to help replace the normal gut flora and decrease nausea and vomiting (Heta & Robo, 2018). Having the patient eat yogurt, may be an easy way for him to consume a probiotic. I would continue both of his currently prescribed antibiotics as they fall under the current guidelines of treating inpatient CAP. It is obvious that the medication are helping him as his condition is improving. Hopefully, his nausea and vomiting will improve soon. He could be prescribed an antiemetic, such as Zofran, to help with his side effects. I would be sure to educate the patient on the need for IV antibiotics and that his side effects should ease up soon. It will be important to instruct him to finish his course of antibiotics up discharge as well. It is important for him to understand that the entire course needs to be completed in order to help prevent antibiotic resistance.
References
Heta, S., & Robo, I. (2018). The side effects of the most commonly used group of antibiotics in periodontal treatments. Medical Sciences, 6(1), 6. https://doi.org/10.3390/medsci6010006
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I., & Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45–e67. https://doi.org/10.1164/rccm.201908-1581st
Michigan Medicine. (n.d.). Medicines that can cause nausea and vomiting. Retrieved July 29, 2020, from https://www.uofmhealth.org/health-library/sig56596
Rubric Detail
Select Grid View or List View to change the rubric’s layout.
Name: NURS_6521_Week11_Assignment_RubricGrid ViewList ViewExcellent Good Fair PoorExplain the circumstances under which children should be prescribed drugs for off-label use. Be specific and provide examples.36 (36%) – 40 (40%)The response accurately and thoroughly explains in detail the circumstances under which children should be prescribed drugs for off-label use.
The response includes accurate and specific examples that fully support the explanation provided.32 (32%) – 35 (35%)The response accurately explains the circumstances under which children should be prescribed drugs for off-label use.
The response includes accurate examples that support the explanation provided.28 (28%) – 31 (31%)The response inaccurately or vaguely explains the circumstances under which children should be prescribed drugs for off-label use.
The response includes inaccurate or vague examples that may or may not support the explanation provided.0 (0%) – 27 (27%)The response inaccurately and vaguely explains the circumstances under which children should be prescribed drugs for off-label use, or is missing.
The response includes inaccurate and vague examples that do not support the explanation provided, or is missing.Explain strategies to making off-label use and dosage of drugs safer for children from infancy to adolescence and descriptions and names of off-label drugs that require extra care and attention when used in pediatrics. Be specific.41 (41%) – 45 (45%)The response accurately and clearly describes in detail strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence.
The response includes accurate, complete, and detailed descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.36 (36%) – 40 (40%)The response accurately describes strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence.
The response includes accurate descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.32 (32%) – 35 (35%)The response inaccurately or vaguely describes strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence.
The response includes inaccurate or vague descriptions and names of off-label drugs that require extra care and attention when used in pediatrics.0 (0%) – 31 (31%)The response inaccurately and vaguely describes strategies to make the off-label use and dosage of drugs safer for children from infancy to adolescence, or is missing.
The response includes inaccurate and vague or incomplete descriptions and names of off-label drugs that require extra care and attention when used in pediatrics, or is missing.Written Expression and Formatting – Paragraph Development and Organization:Paragraphs make clear poin
Order a similar assignment, and have writers from our team of experts write it for you, guaranteeing you an A
